SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-07-242277
Filing Date
2007-11-09
Accepted
2007-11-09 15:19:48
Documents
7
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 635521
2 AMENDMENT TO EMPLOYMENT AGREEMENT dex1062.htm EX-10.62 5918
3 ADDENDUM NO. 4 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT dex1063.htm EX-10.63 83410
4 FORM OF RESTRICTED STOCK UNIT AWARD dex1064.htm EX-10.64 39168
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) & 15D-14(A) dex311.htm EX-31.1 9173
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) & 15D-14(A) dex312.htm EX-31.2 9196
7 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5753
  Complete submission text file 0001193125-07-242277.txt   789523
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 071231076
SIC: 2834 Pharmaceutical Preparations